Eli Lilly and Company

Consultor(a) Técnico(a) Sênior - Imunologia - São Paulo/SP

Brazil

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, ImmunologyIndustries

Requirements

Candidates should possess a relevant higher education degree, such as a Bachelor's degree, and ideally a postgraduate degree in a related field. Prior experience as a Technical Consultant in the immunology and high-cost medication market is considered a differential. Strong English language skills are required, with an intermediate level preferred. Familiarity with Microsoft Office, IOS, and auditing tools is also necessary.

Responsibilities

The Senior Technical Consultant will engage in medical promotion, commercial negotiation, and provide access support for immunobiological and specific target medications within the immunology market. They will establish integration with various Lilly teams (Medical, Marketing, Access, OCE, and Commercial), aiming to implement marketing strategies and surpass product demand results, ultimately improving patient quality of life. The role involves providing technical consultation for Dermatitis Atopic, Psoriasis, and Psoriatic Arthritis, alongside consulting on access to high-cost treatments and commercial negotiation. They will also engage in hybrid visits (in-person and virtual) and utilize OCE tools, fostering client engagement, and managing strategic accounts (SAM). Furthermore, they will possess knowledge of the pharmaceutical high-cost market, the private and public healthcare systems, and demonstrate autonomy in utilizing Microsoft Office, IOS, and auditing tools.

Skills

Autogerenciamento
Automotivação
Pensamento estratégico
Foco em resultados
Análise
Planejamento
Execução
Mensuração
Adaptabilidade
Resiliência
Engajamento multicanal
Visitas híbridas
Ferramentas de OCE
Técnicas de vendas
Negociação comercial
Gerenciamento estratégico de contas

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI